Cargando…
In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris
Introduction: Clopidogrel is a potent platelet activation and aggregation inhibitor that prevents thrombosis in coronary artery diseases (CADs). In comparison to locally produced generic one (Osvix®), original brand of clopidogrel (Plavix®) is expensive. This study was designed to evaluate the effec...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787330/ https://www.ncbi.nlm.nih.gov/pubmed/29391931 http://dx.doi.org/10.15171/jcvtr.2017.33 |